USE OF GPR119 RECEPTOR AGONISTS FOR INCREASING BONE MASS AND FOR TREATING OSTEOPOROSIS, AND COMBINATION THERAPY RELATING THERETO
Predstavljeni pronalazak se odnosi na primjenu agonista GRP119 receptora za liječenje ili prevenciju stanja koje karakteriše niska koštana masa, kao što je osteoporoza, i za povećanje koštane mase kod jedinki. Predstavljeni pronalazak se dalje odnosi na primjenu agonista GPR119 receptora u konbinaci...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Bosnian English |
Published |
10.10.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Predstavljeni pronalazak se odnosi na primjenu agonista GRP119 receptora za liječenje ili prevenciju stanja koje karakteriše niska koštana masa, kao što je osteoporoza, i za povećanje koštane mase kod jedinki. Predstavljeni pronalazak se dalje odnosi na primjenu agonista GPR119 receptora u konbinaciji sa inhibitorom dipepti dil pepti daze IV (DPP-IV) za liječenje i prevenciju stanja koje karakteriše niska koštana masa, kao što je osteoporoza, i za povećanje koštane mase kod jedinki. Agonist GPR119 receptora i inhibitora DPP-IV sti mulišu formiranje kosti kod jedinki.
The present invention relates to the use of GPR119 receptor agonists for treating or preventing a condition characterized by low bone mass, such as osteoporosis, and for increasing bone mass in an individual. The present invention further relates to the use of a GPR119 receptor agonist in combination with a dipeptidyl peptidase IV (DPP-IV) inhibitor for treating or preventing a condition characterized by low bone mass, such as osteoporosis, and for increasing bone mass in an individual. A GPR119 receptor agonist and the combination of a GPR119 receptor agonist and a DPP-IV inhibitor promote bone formation in an individual. |
---|---|
AbstractList | Predstavljeni pronalazak se odnosi na primjenu agonista GRP119 receptora za liječenje ili prevenciju stanja koje karakteriše niska koštana masa, kao što je osteoporoza, i za povećanje koštane mase kod jedinki. Predstavljeni pronalazak se dalje odnosi na primjenu agonista GPR119 receptora u konbinaciji sa inhibitorom dipepti dil pepti daze IV (DPP-IV) za liječenje i prevenciju stanja koje karakteriše niska koštana masa, kao što je osteoporoza, i za povećanje koštane mase kod jedinki. Agonist GPR119 receptora i inhibitora DPP-IV sti mulišu formiranje kosti kod jedinki.
The present invention relates to the use of GPR119 receptor agonists for treating or preventing a condition characterized by low bone mass, such as osteoporosis, and for increasing bone mass in an individual. The present invention further relates to the use of a GPR119 receptor agonist in combination with a dipeptidyl peptidase IV (DPP-IV) inhibitor for treating or preventing a condition characterized by low bone mass, such as osteoporosis, and for increasing bone mass in an individual. A GPR119 receptor agonist and the combination of a GPR119 receptor agonist and a DPP-IV inhibitor promote bone formation in an individual. |
Author | CHU, ZHI-LIANG LEHMANN, JUERG JONES, ROBERT M LEONARD, JAMES N |
Author_xml | – fullname: CHU, ZHI-LIANG – fullname: JONES, ROBERT M – fullname: LEONARD, JAMES N – fullname: LEHMANN, JUERG |
BookMark | eNqFzU0KwjAQBeAsdOHfFWQOoGBVUJdpnLYBmwmZuHBVisSVtIV6AI9uW927Gt77HsxUjKq6ChPxvjICJZBaF0UncKjQenIgUzKaPUPSBW2UQ8napBCTQcglM0hzHtB35Hsi9kiWHLHm1cCK8libTsmAz9BJe-s-XL7zvkBPczF-lM82LH53JpYJepWtQ1MXoW3Ke6jCq8jRbg_7zVHu_g4-YHg80A |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | AGONISTI GPR119 RECEPTORA U POSTUPCIMA ZA POVEĆANJE KOŠTANE MASE I ZA LIJEČENJE OSEOPOROZE, KAO I DRUGIH STANJA KOJA KARAKTERIŠE NISKA KOŠTANA MASA I SA NJIMA POVEZANA KOMBINOVANA TERAPIJA. |
ExternalDocumentID | MEP27408A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_MEP27408A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:59:13 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Bosnian English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_MEP27408A3 |
Notes | Application Number: ME2008P000274 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101010&DB=EPODOC&CC=ME&NR=P27408A |
ParticipantIDs | epo_espacenet_MEP27408A |
PublicationCentury | 2000 |
PublicationDate | 20101010 |
PublicationDateYYYYMMDD | 2010-10-10 |
PublicationDate_xml | – month: 10 year: 2010 text: 20101010 day: 10 |
PublicationDecade | 2010 |
PublicationYear | 2010 |
RelatedCompanies | ARENA PHARMACEUTICALS, INC |
RelatedCompanies_xml | – name: ARENA PHARMACEUTICALS, INC |
Score | 2.790367 |
Snippet | Predstavljeni pronalazak se odnosi na primjenu agonista GRP119 receptora za liječenje ili prevenciju stanja koje karakteriše niska koštana masa, kao što je... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | USE OF GPR119 RECEPTOR AGONISTS FOR INCREASING BONE MASS AND FOR TREATING OSTEOPOROSIS, AND COMBINATION THERAPY RELATING THERETO |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101010&DB=EPODOC&locale=&CC=ME&NR=P27408A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT8MgFCdzGvWm8_tj4WB6srG4busOjWkp3WrS0hRm5smMlhkv2-JqvPqnS7FTLwscCD9C8kjegx_w3gPgJncKYcuB4iYISdMunJ45lTI3pUS92RTNlN2srgbipDca24-T7qQBXte-MDpO6KcOjqg0Klf6Xmp7vfy7xAr038rVnXhTXYuHkLuBUbNjpIsR-C5JaUCxgbEbEyPJ3FSxL8vxtsC2OkP3q79f5MmvXFKW__eT8ADspGqqeXkIGmLVAnt4nXatBXbj-rVbNWvFWx2BrzEjkIZwmGYIDWBGMEk5zaA3pEnEOIOKzEFF0DPisSgZQp8mBMYeY9BLAg1yBfEKoowTmtKMsojdahjT2I9-wuJCPiKZlz7DKpWGHl51EE6PQTskHI9MJcrL76K9xKQWuXMCmvPFXJ4BKB2nO5DFTCAk7MqFdNrp5_a91bUKJBxLnIPTDZNcbEQuwb5-UNf1CjTL9w95rfbpUrT1Gn8DuxaPFg |
link.rule.ids | 230,309,783,888,25578,76886 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT8MgFCdzGudN5_cnB9OTjcV1szs0ph90ra6lKczM0zJaZrxsi5vx6p8uxU69LHAg70dIIHnv8QPeA4Dr3Cq4KbqSmyAkdLOwOvpYiFwXAnUmYzSRdrM8GoiTTjgwH4ftYQ28rmJhVJ7QT5UcUWpULvV9qez1_O8Qy1dvKxe3_E2KZg8Bs32tYsdIFc13bZwSn3ia59kx1pLMTiX7MixnA2zK_bVVqgJ-dsuQlPl_fxLsgq1UDjVd7oEaXzRBw1t9u9YE23F12y2bleIt9sHXgGJIAthLM4S6MMMeThnJoNMjSUQZhZLMQUnQM-zQKOlBlyQYxg6l0El8BTIJsRIilGGSkozQiN4o2COxG_2kxYUsxJmTvsDyKw3VvRRgRg7AZYCZF-pyKqPfRRvFuJpy6xDUp7OpOAZQWFa7K4oJR4ibZQjpuHWfm3dG2ygQtwx-Ao7WDHK6FrkCjZDF_VE_Sp7OwI66XFf1HNSX7x_iQvrsJb9U6_0NnaeSCA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=USE+OF+GPR119+RECEPTOR+AGONISTS+FOR+INCREASING+BONE+MASS+AND+FOR+TREATING+OSTEOPOROSIS%2C+AND+COMBINATION+THERAPY+RELATING+THERETO&rft.inventor=CHU%2C+ZHI-LIANG&rft.inventor=JONES%2C+ROBERT+M&rft.inventor=LEONARD%2C+JAMES+N&rft.inventor=LEHMANN%2C+JUERG&rft.date=2010-10-10&rft.externalDBID=A&rft.externalDocID=MEP27408A |